BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Daiichi Sankyo
US Army
US Department of Justice

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077743

« Back to Dashboard

NDA 077743 describes RIBAVIRIN, which is a drug marketed by Sandoz, Teva, Zydus Pharms Usa, Navinta Llc, Aurobindo Pharma, Kadmon Pharms Llc, and Sandoz Inc, and is included in ten NDAs. It is available from eleven suppliers. Additional details are available on the RIBAVIRIN profile page.

The generic ingredient in RIBAVIRIN is ribavirin. There are fifteen drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the ribavirin profile page.
Summary for 077743
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details
Pharmacology for NDA: 077743
Ingredient-typeNucleoside Analog
Medical Subject Heading (MeSH) Categories for 077743
Suppliers and Packaging for NDA: 077743
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
RIBAVIRIN ribavirin TABLET;ORAL 077743 ANDA Sandoz Inc 0781-5177 0781-5177-04 84 TABLET, FILM COATED in 1 BOTTLE (0781-5177-04)
RIBAVIRIN ribavirin TABLET;ORAL 077743 ANDA Sandoz Inc 0781-5177 0781-5177-67 70 TABLET, FILM COATED in 1 BOTTLE (0781-5177-67)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength200MG
Approval Date:Oct 3, 2006TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
US Department of Justice
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.